1650 related articles for article (PubMed ID: 31848460)
21. Radiotherapy to Enhance Chimeric Antigen Receptor T-Cell Therapeutic Efficacy in Solid Tumors: A Narrative Review.
Hauth F; Ho AY; Ferrone S; Duda DG
JAMA Oncol; 2021 Jul; 7(7):1051-1059. PubMed ID: 33885725
[TBL] [Abstract][Full Text] [Related]
22. Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography.
Sakemura R; Cox MJ; Bansal A; Roman CM; Hefazi M; Vernon CJ; Glynn DL; Pandey MK; DeGrado TR; Siegler EL; Kenderian SS
J Vis Exp; 2022 Feb; (180):. PubMed ID: 35253798
[TBL] [Abstract][Full Text] [Related]
23. [Indications for CAR-T cell therapy and management of the complications: an update].
Di Lorenzo S; Errichiello S; Cerne D; Venturini M; Visintini C
Assist Inferm Ric; 2022; 41(4):195-211. PubMed ID: 37283174
[TBL] [Abstract][Full Text] [Related]
24. CAR-T Cells and Oncolytic Viruses: Joining Forces to Overcome the Solid Tumor Challenge.
Guedan S; Alemany R
Front Immunol; 2018; 9():2460. PubMed ID: 30405639
[TBL] [Abstract][Full Text] [Related]
25. Engineered T Cells: CAR T Cell Therapy and Beyond.
Johnson PC; Abramson JS
Curr Oncol Rep; 2022 Jan; 24(1):23-31. PubMed ID: 35059997
[TBL] [Abstract][Full Text] [Related]
26. Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors.
Kosti P; Maher J; Arnold JN
Front Immunol; 2018; 9():1104. PubMed ID: 29872437
[TBL] [Abstract][Full Text] [Related]
27. Engineering CAR-T Cells for Next-Generation Cancer Therapy.
Hong M; Clubb JD; Chen YY
Cancer Cell; 2020 Oct; 38(4):473-488. PubMed ID: 32735779
[TBL] [Abstract][Full Text] [Related]
28. Development of CAR T cells designed to improve antitumor efficacy and safety.
Jaspers JE; Brentjens RJ
Pharmacol Ther; 2017 Oct; 178():83-91. PubMed ID: 28342824
[TBL] [Abstract][Full Text] [Related]
29. Chimeric Antigen Receptors for the Tumour Microenvironment.
Habib R; Nagrial A; Micklethwaite K; Gowrishankar K
Adv Exp Med Biol; 2020; 1263():117-143. PubMed ID: 32588326
[TBL] [Abstract][Full Text] [Related]
30. Befriending the Hostile Tumor Microenvironment in CAR T-Cell Therapy.
Lindo L; Wilkinson LH; Hay KA
Front Immunol; 2020; 11():618387. PubMed ID: 33643299
[TBL] [Abstract][Full Text] [Related]
31. Immunobiology of chimeric antigen receptor T cells and novel designs.
Walsh Z; Yang Y; Kohler ME
Immunol Rev; 2019 Jul; 290(1):100-113. PubMed ID: 31355496
[TBL] [Abstract][Full Text] [Related]
32. Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon.
Martino M; Naso V; Loteta B; Canale FA; Pugliese M; Alati C; Musuraca G; Nappi D; Gaimari A; Nicolini F; Mazza M; Bravaccini S; Derudas D; Martinelli G; Cerchione C
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362130
[TBL] [Abstract][Full Text] [Related]
33. CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment.
Martinez M; Moon EK
Front Immunol; 2019; 10():128. PubMed ID: 30804938
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic roles of CAR T cells in infectious diseases: Clinical lessons learnt from cancer.
Mohammadi M; Akhoundi M; Malih S; Mohammadi A; Sheykhhasan M
Rev Med Virol; 2022 Jul; 32(4):e2325. PubMed ID: 35037732
[TBL] [Abstract][Full Text] [Related]
35. CAR-Ts: new perspectives in cancer therapy.
Abrantes R; Duarte HO; Gomes C; Wälchli S; Reis CA
FEBS Lett; 2022 Feb; 596(4):403-416. PubMed ID: 34978080
[TBL] [Abstract][Full Text] [Related]
36. Driving CARs on the Highway to Solid Cancer: Some Considerations on the Adoptive Therapy with CAR T Cells.
Abken H
Hum Gene Ther; 2017 Nov; 28(11):1047-1060. PubMed ID: 28810803
[TBL] [Abstract][Full Text] [Related]
37. Cancer Immunotherapy Using CAR-T Cells: From the Research Bench to the Assembly Line.
Gomes-Silva D; Ramos CA
Biotechnol J; 2018 Feb; 13(2):. PubMed ID: 28960810
[TBL] [Abstract][Full Text] [Related]
38. CAR-T cell and Personalized Medicine.
Cruz-Ramos M; García-Foncillas J
Adv Exp Med Biol; 2019; 1168():131-145. PubMed ID: 31713169
[TBL] [Abstract][Full Text] [Related]
39. CAR-T Cells for Cancer Treatment: Current Design and Next Frontiers.
Picanço-Castro V; Swiech K; Malmegrim KCR; Covas DT
Methods Mol Biol; 2020; 2086():1-10. PubMed ID: 31707664
[TBL] [Abstract][Full Text] [Related]
40. Engineering Next-Generation CAR-T Cells: Overcoming Tumor Hypoxia and Metabolism.
Gao TA; Chen YY
Annu Rev Chem Biomol Eng; 2022 Jun; 13():193-216. PubMed ID: 35700528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
